US health body questions authenticity of AstraZeneca COVID-19 vaccine trial data
Washington: Results from a US trial of AstraZeneca’s COVID-19 vaccine may have used ‘outdated information’, US federal health officials said early Tuesday. The Data and Safety Monitoring Board said in a statement that it was concerned that AstraZeneca may have provided an incomplete view of...











































